Alto Neuroscience, Inc.

The current price of ANRO is $21.87 — it has decreased by 6.14% since the previous close. Data as of Nov 5, 2026.

ANRO is down 5.77% over the past week, down 8.91% over the past month and up 93.71% over the past year. The price is below its 200-day moving average of $24.34.

Analysts' average 12-month price target for ANRO is $39.25, which implies 79.47% upside from the current price. Individual estimates range from $24.00 to $60.00.

Alto Neuroscience, Inc. has a market capitalization of $858.22M. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.

In its most recent quarterly report, Alto Neuroscience, Inc. posted a loss of $0.65 per share against an estimate of -$0.7345, beating expectations by 11.51%. Upcoming reports are listed in the earnings calendar.

Alto Neuroscience, Inc. has not paid any dividends over the past year.

Companies most comparable to Alto Neuroscience, Inc. include Alpha Tau Medical Ltd, Silence Therapeutics plc, Contineum Therapeutics, Inc., Larimar Therapeutics, Inc. and Amarin Corporation plc.

In the latest trading session ANRO moved between $21.83 and $23.28, a range of 6.63% of its current price.

Over the past 52 weeks ANRO has traded between $10.62 and $37.48. The current price is 41.65% below its 52-week high.